Bill Text

PDF |Add To My Favorites |Track Bill | print page

ACR-163 Colorectal Cancer Awareness Month. (2017-2018)

SHARE THIS:share this bill in Facebookshare this bill in Twitter

Revised  March 19, 2018
Amended  IN  Assembly  February 21, 2018


Assembly Concurrent Resolution No. 163

Introduced by Assembly Member Members Flora and Baker
(Coauthors: Assembly Members Acosta, Aguiar-Curry, Travis Allen, Arambula, Berman, Bigelow, Bloom, Bonta, Burke, Caballero, Calderon, Carrillo, Cervantes, Chávez, Chen, Chiu, Choi, Chu, Cooley, Cooper, Dahle, Daly, Eggman, Fong, Frazier, Friedman, Eduardo Garcia, Gipson, Gloria, Gonzalez Fletcher, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, Mayes, McCarty, Medina, Melendez, Muratsuchi, Nazarian, Obernolte, O’Donnell, Patterson, Quirk, Quirk-Silva, Rendon, Reyes, Rodriguez, Rubio, Salas, Santiago, Mark Stone, Ting, Voepel, Waldron, Weber, and Wood)

January 25, 2018

Relative to Colorectal Cancer Awareness Month.


ACR 163, as amended, Flora. Colorectal Cancer Awareness Month.
This bill would designate March 2018 as Colorectal Cancer Awareness Month in California.
Fiscal Committee: NO  

WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in of Californians, with 14,604 14,400 new cases and 5,195 5,300 deaths expected in 2014; 2018; and
WHEREAS, Colorectal cancer is treatable, curable, and and, in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and

WHEREAS, There are now more than one million survivors of colorectal cancer in the United States; and

WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, 2016, only 55 73 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, FOBTs and fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 39 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean men and Hmong women, and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, Kampuchean, and Hawaiian Pacific Islander men, and the second most common cancer among Chinese, Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hawaiian Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 encourages and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believes that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2018 as Colorectal Cancer Awareness Month in California; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.

Heading—Line 2.